IMPLEMENTATION LEVEL

National

AFFECTED FLOW

Inflow

ANNOUNCED AS TEMPORARY

No

NON-TRADE-RELATED RATIONALE

No

ELIGIBLE FIRMS

all

JUMBO

No

TARIFF PEAK

No
← back to the state act
Inception date: 18 Jul 2013 | Removal date: open ended
Still in force

Financial grant

As a part of the state policy towards modernisation and raising the competitiveness of the Russian economy, the Russian Government approved on 18 July 2013 a road map for the development of the biotechnology and genetic engineering industry. The policy seeks to decrease import dependence, as well the creation of internal demand for products and services of this sector. Among others, the strategic goals of the road map include:

  • Biological products manufactured in Russia should be responsible for approximately 1 per cent of GDP by 2020 and 3 per cent by 2030.
  • Exports of bio-technologies should increase from RUB 1 billion in 2012 to RUB 10 billion in 2015 and to 50 billion in 2018.

The road map mentions explicitly support to local firms through subsidies. The Russian government allocates RUB 1.18 trillion to the development of bio-technologies under 'The Comprehensive Program for Development of Biotechnology in the Russian Federation through 2020' (see related GTA measure 5411 below).

AFFECTED COUNTRIES

MAP
TABLE
EXPORT

Please report this page in case you detect an inaccuracy in its content.